ImageneBio Inc
IMA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $45 | $3,715 | $4,580 |
| Gross Profit | $0 | -$45 | -$3,715 | -$4,580 |
| % Margin | – | – | – | – |
| R&D Expenses | $15,558 | $4,025 | $3,715 | $4,580 |
| G&A Expenses | $11,036 | $4,416 | $5,644 | $7,595 |
| SG&A Expenses | $11,036 | $4,416 | $5,644 | $7,595 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $264 | -$2,280 | -$4,238 |
| Operating Expenses | $26,594 | $8,705 | $7,079 | $7,937 |
| Operating Income | -$26,594 | -$8,750 | -$10,794 | -$12,517 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1,741 | $5,998 | $2,203 | $3,446 |
| Pre-Tax Income | -$24,853 | -$2,752 | -$8,591 | -$9,071 |
| Tax Expense | -$74 | $15 | $28 | $53 |
| Net Income | -$24,779 | -$2,767 | -$8,619 | -$9,124 |
| % Margin | – | – | – | – |
| EPS | -3.005 | -0.057 | -0.18 | -0.19 |
| % Growth | -5,144.7% | 68.2% | 5.3% | – |
| EPS Diluted | -3.005 | -0.057 | -0.18 | -0.19 |
| Weighted Avg Shares Out | 8,527 | 48,258 | 48,258 | 48,258 |
| Weighted Avg Shares Out Dil | 8,527 | 48,258 | 48,258 | 48,258 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,200 | $1,290 | $1,418 | $1,568 |
| Interest Expense | $96 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $87 | $87 | $89 |
| EBITDA | -$24,757 | -$8,354 | -$9,272 | -$12,086 |
| % Margin | – | – | – | – |